Pretreatment of retroviral supernatants with the cationic transgene by polymerase chain reaction (PCR). Colonies liposomes DOTMA-DOPE (Lipofectin), DC-Chol-DOPE from cells infected using centrifugation were positive 27% and DOSPA-DOPE (Lipofectamine) was found to enhance of the time, while the combined approach had positive colstatic transductions of TF-1 target cells. The relative effeconies 31 and 50% of the time for DC-Chol and Lipofectamtiveness at increasing transduction efficiencies (TE) was:
Retrovirus-mediated gene transfer to human target cells exists between the negatively charged virus and cell surface. 2 Enhancement of retrovirus-mediated gene transfer is a complex and multifactorial process consisting of the following steps: movement of the virus in solution to through charge modulation has traditionally been accomplished by the addition of cationic polymers such close proximity of the target cell surface; attachment of the virion through viral envelope proteins to cell surface as polybrene or protamine sulfate to the supernatant. 4 Hodgson et al 5 have recently demonstrated that pretreatreceptors; internalization of the virion into the cell; reverse transcription of viral RNA into DNA; entry into ment of either the target cells or the retroviral vector supernatants with cationic liposomes, such as DOSPAthe nucleus with subsequent integration of the doublestranded DNA nucleoprotein complex into the host's cell DOPE (Lipofectamine), DOTMA-DOPE (Lipofectin), or DOTAP could significantly enhance retroviral transducgenome; and subsequent expression of the transgene product. 1, 2 Overall success is dependent upon the cumulative tion efficiency (TE). This enhancement is several-fold greater than that obtainable with polybrene treatment success of all steps. Examination of the factors which may inhibit each step as well as the discovery of methodalone, and was shown not to arise due to the creation of nonspecific envelope glycoprotein interactions replacing ologies which enhance them could prove useful for improving gene transfer.
the normal receptor-mediated process. These results strongly implicate the reduction of the repulsive force The first step in retrovirus-mediated gene transfer is the movement of the viral particles in suspension to the between the virus and cell surface as the primary mechanism responsible for increased viral uptake and close proximity of the cell surface. This is a random process and can be described by Brownian motion. 3 At the improved TE. Similarly, Fasbender et al 6 have recently demonstrated final stage of approach, as the virus moves closer to the cell it must overcome the electrostatic repulsive force that that pretreatment of adenoviral vectors with cationic polymers, including cationic liposomes, could increase binding and expression of the adenovirus-mediated through an alternative pathway other than the adenoobtained following a standard infection was observed. Additionally, this value represents a 2.2-fold increase virus fiber and its cellular receptor.
We have previously demonstrated that centrifugation over the results obtained with centrifugal enhancement alone. The combined approach of centrifuging target cells of the target cells with the retroviral vector supernatant is a safe and simple method which can significantly with liposome pretreated supernatants was synergistic for all samples evaluated except for Lipofectin. increase TE. 7 In this study, we made a direct comparison of the two methods and investigated the possibility that Although these findings were obtained using the established cell line TF-1, they prompted us to determine if pretreatment of retroviral vector supernatants with cationic liposomes combined with centrifugation could prosimilar results could be obtained with primary CD34 + cells as targets. As part of our preparation for a phase I duce a synergistic effect, resulting in a TE greater than that achieved with cationic lipids or centrifugation alone.
clinical trial, we had already demonstrated that successful transfer of retrovirus-mediated cDNA into CD34 + cells We first determined the optimal dosing of each liposomal formulation to use with the retroviral supernatants isolated from the BM, cord blood and mobilized peripheral blood is possible. [10] [11] [12] [13] We have also shown that cenwhen combined with centrifugal enhancement. The three different liposomes studied were Lipofectamine trifugation can be used to enhance the transduction efficiency of retrovirus-mediated gene transfer into (DOSPA-DOPE 3:1 weight to weight (w/w)), Lipofectin (DOTMA-DOPE 1:1 (w/w)) and DC-Chol-DOPE lipo-CD34 + cells. 7 In our laboratory, we have adopted the following standard protocol for retrovirus-mediated gene somes (DC-Chol-DOPE 3:2 (w/w)). 8, 9 Supernatants from producer cells were pretreated with varying concentransfer into CD34 + cells. Cells are incubated overnight in long-term bone marrow culture medium suptrations of the three liposomal formulations, added to TF-1 cells, and then centrifuged. Following a 3-day incuplemented with the cytokines IL-3, IL-6 and stem cell factor, and infected the following day by centrifugation of bation, the cells were collected and assayed for gene product. Lipofectamine exhibited a classical dose-response the cells with retroviral supernatant supplemented with PS. Naturally, we were curious to see whether cationic curve over the range 0.5 m to 2.0 m, with optimal enhancement occurring at a concentration of 1.5 m.
liposome pretreatment combined with centrifugation could produce a further increase in the results obtained When DC-Chol-DOPE liposomes were used, enhancement occurred at all concentrations tested with the largest utilizing our standard protocol. The results are summarized in Table 1 . For mobilized peripheral blood normal increase in enzymatic activity occurring at doses between 7.5 and 10 m. No significant enhancement for Lipofectin CD34 + cells, the average baseline value of glucocerebrosidase-specific activity is approximately 140 ± 20 U/mg of was observed at any concentration, although the best activity occurred at a concentration of 5.0 m. Based on protein.
In this experiment, non-infected CD34 + cells had an enzymatic activity of 127 U/mg of protein. Cells these results, all subsequent experiments with the liposomes Lipofectamine, DC-Chol-DOPE and Lipofectin infected by the standard procedure gave an average increase in enzymatic activity above background of 76 U. were performed at concentrations of 1.5, 7.5 and 5.0 m, respectively.
Supernatants pretreated with DC-Chol-DOPE liposomes or Lipofectamine had an average increase above backIn the first experiment, TF-1 target cells (n = 3) were infected with supernatants which were pretreated with ground of 100 and 157 U, respectively, representing a 1.3-and 2.1-fold increase over the values obtained with the protamine sulfate (PS), each liposomal formulation, a combination of both or untreated. Following a 3-day conventional procedure. Transduction efficiency of CD34 + cells, determined as the number of PCR-positive incubation the target cells were collected and assayed for specific enzymatic activity. 7 The mean and standard error colonies for the transgene divided by the total number of colonies assayed, was also enhanced with liposome preof the mean are summarized in Figure 1 . For noncentrifuged samples, pretreatment of supernatants with Lipotreatment of the supernatant. Using the standard procedure, 28% of the colonies from infected cells were PCR fectin, protamine sulfate or both, had no significant effect on TE. However, pretreatment of supernatants with DCpositive for the transgene. Colonies from cells infected with DC-Chol-DOPE liposomes or Lipofectamine preChol-DOPE liposomes and Lipofectamine, either with or without PS did significantly increase the TE of the target treated supernatants were positive for the transgene 31 and 50% of the time, respectively. Although the sample cells. Lipofectamine was more effective than DC-Chol-DOPE liposomes at increasing TE, having an 11.9-fold size is small, these results for CD34 + are in agreement with the results for enzymatic activity, suggesting that a increase compared with a 6.2-fold increase. Interestingly, the addition of PS to the liposome-supernatant mixture two-fold increase in TE can be obtained through pretreatment of retroviral supernatants with the cationic lipoduring pretreatment resulted in a significant decrease in this enhancement potential.
some Lipofectamine. We have previously shown that for centrifugation of Centrifugation alone was capable of enhancing retrovirus-mediated gene transfer and resulted in a 25.6-fold target cells and supernatant, the increase in transduction efficiency is proportional to both time and increasing cenincrease over the values obtained after conventional infection. All samples which were centrifuged had a trifugal force. 7 This direct relationship between increasing TE and increasing centrifugal force plateaus at greater TE than those which were not. The TE of cells centrifuged with supernatants pretreated with PS, Lipo-10 000 g, and no further enhancement can be obtained.
We observed that cells infected with Lipofectamine prefectin and PS, DC-Chol-DOPE liposomes with or without PS, were not significantly different from each other, but treated supernatants at 1 g had a 12-fold increase compared with cells infected with supernatant only, while at were higher than that of cells centrifuged with supernatant alone. Centrifugation of target cells with Lipofec-2400 g, a 2.3-fold increase was observed. We speculated that the increase in TE attributable to pretreatment of the tamine-pretreated supernatants was superior to all other treatments and an increase of 57-fold over what can be supernatants with liposomes would decrease with 15 The creation and culture requirements of the MFG-GC producer, as well as the method used for production of supernatant from it, has been described elsewhere. 10 Supernatant supplemented with protamine sulfate (4 g/ml)
76 ± 11 9/32 = 28% Supernatant pretreated with DC-Chol-DOPE liposomes (10.0 m) 100 ± 3 5/16 = 31% Supernatant pretreated with Lipofectamine (1.5 m)
157 ± 10 8/16 = 50% Enrichment and culture of CD34 + cells from peripheral blood was as described. 16 Target cells were suspended in culture medium (longterm bone marrow culture medium supplemented with the cytokines IL-3, IL-6 and stem cell factor) at a concentration of 2.0 × 10 5 cells/ml. One ml aliquots were placed into 14-ml round-bottom tubes (Falcon, Lincoln Park, NJ, USA) and an equal volume of each retroviral supernatant mixture was then added to each tube. The tubes were mixed and then centrifuged for 2 h at 24°C. At the end of the transduction period, the supernatant was removed and the cells resuspended in fresh medium. After incubation for 3 days at 37°C, cells were harvested, rinsed twice in PBS and analyzed by enzyme assay. 10 The transduction efficiency of both non-infected and infected CD34
+ cells was determined through PCR of CFU-GM colonies as previously described. increasing centrifugal force and would have no effect at natants. Most cationic liposomes are a combination of a cationic lipid and the neutral lipid, DOPE. For normal the previously established plateau. If correct, this would suggest that in addition to our previously postulated liposome-mediated gene transfer, the fusigenic and endosome disrupting properties of DOPE are thought to be mechanism, centrifugation may also assist the virus in overcoming the electrostatic repulsive force between the mechanism whereby plasmid DNA is carried into the cell, and released from the endosomes into the cytosol. itself and the cell. Supernatants were pretreated with 1.5 m Lipofectamine and compared with untreated Since retrovirus-mediated gene transfer is known to occur only through a receptor-mediated process, we supernatants for their ability to infect TF-1 target cells at various centrifugal forces. The mean and standard error attempted to determine if liposomal pretreatment of the supernatant was providing an alternative pathway for of the mean (n = 3) for samples centrifuged over the range of 1 to 10 000 g are shown in Figure 2 . With increasing viral entry into the cell, via the creation of a nonreceptormediated, endocytotic pathway. DOPC is an analog of centrifugal force, the transduction efficiency of cells infected with either the liposome pretreated or untreated DOPE in which the ethanolamine head group has been replaced with a choline. This lipid lacks the fusigenic supernatants increases. However, at all points tested, the TE of cells infected with the pretreated supernatants was properties of DOPE and when combined with DOSPA produces liposomes which are inefficient at transfecting significantly better than that from cells infected with the untreated supernatants. As expected, the magnitude of cells with plasmid DNA. Commercially available Lipofectamine (DOSPA-DOPE (3:1 w/w)), DOSPA-DOPE (3:1 the overall difference between the two methods did decrease with increasing centrifugal force. The enzymatic w/w) and DOSPA-DOPC (3:1 w/w) liposomes produced in our laboratory, and PS were evaluated for their activity of the cells infected with Lipofectamine pretreated supernatants and infected at 1 g was eight-fold ability to infect TF-1 target cells at increasing centrifugal forces. The mean and standard error of the mean (n = 3) higher than the activity of cells infected with untreated supernatant. At each successive point examined, the for samples centrifuged over the range of 1 to 12 500 g are shown in Figure 3 . With increasing centrifugal force, overall difference in enzymatic activity between the two methods decreased, and at 10 000 g, this increase in TE the transduction efficiency for all groups tested increased proportionally. The addition of PS to the supernatant was was only 1.4-fold greater than the value obtained from cells infected with supernatant only. marginally effective at increasing the TE of cells infected at lower centrifugal forces, but was not statistically differThis finding was unexpected and forced us to speculate about possible mechanisms to explain this increase in TE ent from that of cells infected with supernatant alone at higher centrifugal forces. From previous experiments of cells centrifuged with Lipofectamine pretreated super- 
target cells with increasing centrifugal forces for 2 h at 24°C. After infection, the medium was changed and the cells incubated for 3 days. The cells were then harvested and an
enzyme assay specific for glucocerebrosidase activity performed. 7 The mean and standard error of the mean for each sample were then calculated.
Figure 3 Effect of liposomal formulation used for retroviral pretreatment and increasing centrifugal force. Retroviral supernatants (CC2) were pretreated with Lipofectamine (LFA), DOSPA-DOPE 3:1 w/w (D/E 3:1), DOSPA-DOPC 3:1 w/w (D/C 3:1) liposomes, protamine sulfate (PS), and then used to infect 1.5 × 10 5 TF-1 target cells with increasing centrifugal forces for 2 h at 24°C in triplicate. After infection, the medium was changed and the cells incubated for 3 days. The cells were then harvested and an enzyme assay specific for glucocerebrosidase activity performed.
7 The mean and standard error of the mean for each sample were then calculated.
(data not published) we have observed that the TE of by attempting to infect CHO-K1 cells with an amphotropic retrovirus. CHO-K1 cells are generally resistant to cells infected with centrifugal enhancement and PS supplemented supernatants is often better than that of cells retroviral infection from vectors with an amphotropic host range. Amphotropic MFG-lacZ retroviral vectors infected with nontreated supernatants. The TE of cells infected with liposome pretreated supernatants using any were pretreated with protamine sulfate, DOSPA-DOPE liposomes at 3:1 or 1:1 w/w ratios, DOSPA-DOPC lipoof the three cationic liposomes was superior to protamine sulfate and the untreated supernatants at every point somes at 3:1 or 1:1 w/w ratios, or with commercial Lipofectamine and assessed for their ability to infect CHO-K1 examined. As a control, we compared the increase in TE from cells infected with supernatants pretreated with the cells. Infections were performed in duplicate. Following X-gal staining, blue cells were counted for evaluation of commercially available Lipofectamine, with the increase observed for cells infected with supernatants pretreated TE and the results presented in Table 2 . In one of the noninfected wells, one blue cell was observed. Cells infected with the DOSPA-DOPE liposomes we produced in our laboratory. At every point tested, there was no significant with supernatants supplemented with PS had the highest average number of positive cells. There was no significant difference between the two. Having established that the DOSPA-DOPE liposomes we produced were funcdifference between the cells infected with supernatants pretreated with Lipofectamine, DOSPA-DOPE 3:1 w/w, tionally active, we compared the TE of cells infected with supernatants pretreated with liposomes composed of or DOSPA-DOPC 3:1 w/w liposomes. Cells infected with supernatants pretreated with liposomes composed of DOPC with those containing the fusigenic lipid DOPE. For cells infected at 1 g, the TE of the cells infected with equal amounts of cationic lipids and neutral lipids DOPE or DOPC were not significantly different from each other, the DOSPA-DOPC pretreated supernatants was less than that for cells infected with either Lipofectamine or the but had a lower TE than cells treated with either protamine sulfate or the 3:1 w/w liposomes. DOSPA-DOPE liposome we produced. At all other points examined, there was no difference between the TE The concept of gene therapy is being studied in many laboratory and clinical experiments. The types of disof cells infected with supernatants which were pretreated with DOSPA-DOPC liposomes, or either of the other orders or conditions that could potentially be treated, types of cells, and different methods used for gene delivtwo liposomes.
From this experiment, it was concluded that pretreatery are many and vast. A wide variety of clinical trials utilizing these different methods for gene transfer are ment of retroviral supernatants with cationic liposomes was not creating a nonreceptor-mediated pathway for currently in progress and the number of trials continues to grow each year. To date, retroviral vectors for gene viral entry into the cell. This observation was confirmed superior to liposomal pretreatment at increasing TE, and repopulating hematopoietic stem cell and allows for direct comparison between different infection protocols to be made. Our data also demonstrated that following pretreatment, the virus-liposome complex retained its tropism transfer continue to be the most commonly used method for gene delivery. Factors which contribute to this are:
and that the increase associated with liposomal pretreatment did not result from a fusigenic process owing to the ability of retroviruses stably to integrate their cDNA into the host cells' genome; nonpathogenicity of the vecthe presence of the fusigenic lipid DOPE in the liposomal formulations used. Since liposomes made at a 1:1 ratio tor; capability to produce supernatants of adequate titer; and the scalability of vector containing supernatant procontain more of the fusigenic lipid DOPE and less of the cationic lipid DOSPA than liposomes made at a 3:1 ratio, duction. Although many of these trials have established gene transfer, few trials have been able to demonstrate if a fusigenic mechanism was responsible, one would postulate that the TE of cells resistant to retroviral infectransduction efficiencies of sufficient magnitude to demonstrate clinical relevance. Therefore, efforts to increase tion from viruses with an amphotropic host range would increase in those cells infected with supernatants prethe efficiency of gene transfer are currently being studied at every stage of the process, including design and engintreated with liposomes containing more of the fusigenic lipid. Since just the opposite occurs, it is less likely that eering of efficient vectors, generation of higher titer producer clones, delineation of each step of the retroviral a fusigenic mechanism is responsible and more suggestive of some form of charge modulation. infection process, and optimization of transduction conditions and procedures.
Furthermore, if the plateau at 10 000 g for the increase in TE with centrifugal enhancement was the result of the It has been demonstrated by Hodgson et al, 5 that pretreatment of retroviral supernatants with cationic lipocentrifugal force on the virus overcoming the strong electrostatic repulsive force between the virus and the cell somes enhances retrovirus-mediated gene transfer. Additionally, they determined that the virus-liposome surface, addition of cationic polymers to the supernatant should have no effect on TE at centrifugal forces greater complex retained its tropism after pretreatment and that the process remained receptor mediated. They also estabthan 10 000 g. For cationic liposomes, including those made with the fusigenic lipid DOPE and those made with lished that pretreatment of the target cells with liposomes followed by retroviral infection was as effective as prethe nonfusigenic lipid DOPC, this was not observed. Rather, at all centrifugal forces evaluated, the highest TE treatment of the virus and subsequent infection of the cells. In this study we obtained similar results and conwere always associated with those cells which had been infected with supernatants that had been pretreated with firmed their observations. Previously, we have shown that centrifugation of tarcationic liposomes. It is interesting to note, that at higher centrifugal forces, the addition of protamine sulfate has get cells with retroviral vector containing supernatants is a simple and safe method to increase TE. 7 Centrifugation no significant effect. This suggests that the mechanism by which these compounds modulate the electrostatic repulwas shown to work for both nonadherent cells, TF-1 and CD34 + , and adherent 3T3 fibroblasts. The increase in TE sive force between the virus and the cell may be different. Although cationic polymers increase the TE of retrowas found to be proportional to time and increasing centrifugal force, but inversely proportional to cell number. viral infections, the exact mechanism whereby this is accomplished is not yet completely understood. PolyFurthermore, at centrifugal forces above 10 000 g, no further enhancement could be obtained. Depending upon brene and protamine sulfate are thought to promote binding of the virus on the cell surface by neutralizing the target cell type, centrifugation could increase TE 10-to 30-fold compared with noncentrifuged controls.
the electrostatic repulsion between the virus and the cell. Recently, Andreadis and Palsson 14 showed that poly-A direct comparison between the two methods described above demonstrated that centrifugation was brene's effectiveness at increasing retroviral transduction is dependent upon the concentration of serum present in aggregates would tend to settle under gravity and this could be enhanced under a centrifugal force. Provided the medium. As the concentration of serum increases, the amount of polybrene needed to achieve optimal TE also that these aggregates are not size excluded, they could possibly bind to the cellular receptor and be internalized increases. They offered two possible explanations for this coupled effect: (1) that PB induced viral aggregation, as an aggregate. In this scenario, the increase in TE would reflect cells being infected by multiple copies in which is dependent upon calf serum concentration and results in loss of retroviral vectors in the form of aggreaggregate.
In conclusion, although several fundamental questions gates that may be less infectious than single virus particles; and (2) that PB is neutralized by negatively concerning the mechanism of action for centrifugation or cationic liposome pretreatment of retroviral supernatants charged serum proteins, a titration effect resulting in decreased levels of polybrene in the medium. Fasbender remain to be answered, both are useful methods at enhancing retrovirus-mediated gene transfer. Direct comet al 6 showed that pretreatment of adenoviral supernatants with poly-l-lysine and Lipofectamine resulted in parison of the two methods revealed that centrifugation was better than cationic liposomal pretreatment at the creation of a nonreceptor-mediated pathway for viral entry. It was established that increasing the concentration increasing retrovirus-mediated gene transfer. Additionally, a combination of the two methods is synergistic and of the cationic polymer to the adenovirus resulted in the formation of larger viral aggregates. However, even at further enhances gene transfer. These results are amenable to a wide variety of cell types, including CD34 + cells, the largest dose, single virus particles could still be detected. Utilizing transmission electron microscopy, it and should help to further the understanding of the retrovirus-mediated gene transfer process, possibly was shown that untreated adenovirus was usually taken up into the cell as single particles, but that multiple allowing clinical trials currently being performed to make use of the improvements in gene transfer. adenovirus particles were present in the endosomes of cells infected with poly-l-lysine and Lipofectamine adenovirus complexes. These results suggest that cationic polymers may cause viruses to form viral aggregates.
